Nagarajan Vijaiganesh, Kohan Luke, Holland Eric, Keeley Ellen C, Mazimba Sula
Department of Cardiovascular Medicine University of Virginia Charlottesville VA USA.
Department of Medicine University of Virginia Charlottesville VA USA.
ESC Heart Fail. 2016 Dec;3(4):227-234. doi: 10.1002/ehf2.12120. Epub 2016 Oct 31.
Obesity and heart failure are two of the leading causes of morbidity and mortality in the world. The relationship between obesity and cardiovascular diseases is complex and not fully understood. While the risk of developing heart failure has been shown to be higher in patients who are obese, there is a survival advantage for obese and overweight patients compared with normal weight or low weight patients. This phenomenon was first described by Horwich and was subsequently confirmed in other large trials. The advantage exists irrespective of the type, aetiology, or stage of heart failure. Patients with morbid obesity (body mass index >40 kg/m), however, do not have the same survival advantage of their obese counterparts. There are several alternative indices of obesity available that may be more accurate than body mass index. The role of weight loss in patients with heart failure is unclear; thus, providing sound clinical advice to patients remains difficult. Future prospective trials designed to evaluate the link between obesity and heart failure will help us understand more fully this complex relationship.
肥胖和心力衰竭是全球发病和死亡的两大主要原因。肥胖与心血管疾病之间的关系复杂,尚未完全明确。虽然肥胖患者发生心力衰竭的风险更高,但与正常体重或低体重患者相比,肥胖和超重患者具有生存优势。这一现象最早由霍里奇描述,随后在其他大型试验中得到证实。无论心力衰竭的类型、病因或阶段如何,这种优势都存在。然而,病态肥胖(体重指数>40kg/m)患者并不具有与其肥胖对应者相同的生存优势。有几种可供选择的肥胖指标,可能比体重指数更准确。心力衰竭患者体重减轻的作用尚不清楚;因此,向患者提供合理的临床建议仍然困难。未来旨在评估肥胖与心力衰竭之间联系的前瞻性试验将有助于我们更全面地理解这种复杂关系。